A Randomized Open-Label Study of Relugolix Alone or Relugolix Combination Therapy in Premenopausal Women

Lukes, A; Migoya, E; Johnson, B; Lee, TY; Li, YL; Ferreira, JCA

Migoya, E (通讯作者),Myovant Sci Inc, 2000 Sierra Point Pkwy,9th Floor, Brisbane, CA 94005 USA.

CLINICAL PHARMACOKINETICS, 2023; 62 (8): 1169

Abstract

Background and ObjectiveRelugolix is a gonadotropin-releasing hormone receptor antagonist. Relugolix 40-mg monotherapy is associated with vasomotor sy......

Full Text Link